229 related articles for article (PubMed ID: 24861817)
21. VOC breath biomarkers in lung cancer.
Saalberg Y; Wolff M
Clin Chim Acta; 2016 Aug; 459():5-9. PubMed ID: 27221203
[TBL] [Abstract][Full Text] [Related]
22. Exhaled volatile organic compounds in patients with non-small cell lung cancer: cross sectional and nested short-term follow-up study.
Poli D; Carbognani P; Corradi M; Goldoni M; Acampa O; Balbi B; Bianchi L; Rusca M; Mutti A
Respir Res; 2005 Jul; 6(1):71. PubMed ID: 16018807
[TBL] [Abstract][Full Text] [Related]
23. Exhaled metabolic markers and relevant dysregulated pathways of lung cancer: a pilot study.
Zou Y; Hu Y; Jiang Z; Chen Y; Zhou Y; Wang Z; Wang Y; Jiang G; Tan Z; Hu F
Ann Med; 2022 Dec; 54(1):790-802. PubMed ID: 35261323
[TBL] [Abstract][Full Text] [Related]
24. Progress in the development of volatile exhaled breath signatures of lung cancer.
Mazzone PJ; Wang XF; Lim S; Jett J; Choi H; Zhang Q; Beukemann M; Seeley M; Martino R; Rhodes P
Ann Am Thorac Soc; 2015 May; 12(5):752-7. PubMed ID: 25965541
[TBL] [Abstract][Full Text] [Related]
25. Volatile organic compounds in human matrices as lung cancer biomarkers: a systematic review.
Janssens E; van Meerbeeck JP; Lamote K
Crit Rev Oncol Hematol; 2020 Sep; 153():103037. PubMed ID: 32771940
[TBL] [Abstract][Full Text] [Related]
26. Detecting cancer by breath volatile organic compound analysis: a review of array-based sensors.
Queralto N; Berliner AN; Goldsmith B; Martino R; Rhodes P; Lim SH
J Breath Res; 2014 Jun; 8(2):027112. PubMed ID: 24862241
[TBL] [Abstract][Full Text] [Related]
27. Volatile organic compounds (VOCs) fingerprint of Alzheimer's disease.
Mazzatenta A; Pokorski M; Sartucci F; Domenici L; Di Giulio C
Respir Physiol Neurobiol; 2015 Apr; 209():81-4. PubMed ID: 25308706
[TBL] [Abstract][Full Text] [Related]
28. Comparison of volatile organic compounds from lung cancer patients and healthy controls-challenges and limitations of an observational study.
Schallschmidt K; Becker R; Jung C; Bremser W; Walles T; Neudecker J; Leschber G; Frese S; Nehls I
J Breath Res; 2016 Oct; 10(4):046007. PubMed ID: 27732569
[TBL] [Abstract][Full Text] [Related]
29. Advances in the early detection of lung cancer using analysis of volatile organic compounds: from imaging to sensors.
Li W; Liu HY; Jia ZR; Qiao PP; Pi XT; Chen J; Deng LH
Asian Pac J Cancer Prev; 2014; 15(11):4377-84. PubMed ID: 24969857
[TBL] [Abstract][Full Text] [Related]
30. Diagnosis by Volatile Organic Compounds in Exhaled Breath from Lung Cancer Patients Using Support Vector Machine Algorithm.
Sakumura Y; Koyama Y; Tokutake H; Hida T; Sato K; Itoh T; Akamatsu T; Shin W
Sensors (Basel); 2017 Feb; 17(2):. PubMed ID: 28165388
[TBL] [Abstract][Full Text] [Related]
31. Metabolomics of volatile organic compounds in cystic fibrosis patients and controls.
Robroeks CM; van Berkel JJ; Dallinga JW; Jöbsis Q; Zimmermann LJ; Hendriks HJ; Wouters MF; van der Grinten CP; van de Kant KD; van Schooten FJ; Dompeling E
Pediatr Res; 2010 Jul; 68(1):75-80. PubMed ID: 20351658
[TBL] [Abstract][Full Text] [Related]
32. Comparative analyses of volatile organic compounds (VOCs) from patients, tumors and transformed cell lines for the validation of lung cancer-derived breath markers.
Filipiak W; Filipiak A; Sponring A; Schmid T; Zelger B; Ager C; Klodzinska E; Denz H; Pizzini A; Lucciarini P; Jamnig H; Troppmair J; Amann A
J Breath Res; 2014 Jun; 8(2):027111. PubMed ID: 24862102
[TBL] [Abstract][Full Text] [Related]
33. Chromatographic analysis of VOC patterns in exhaled breath from smokers and nonsmokers.
Capone S; Tufariello M; Forleo A; Longo V; Giampetruzzi L; Radogna AV; Casino F; Siciliano P
Biomed Chromatogr; 2018 Apr; 32(4):. PubMed ID: 29131420
[TBL] [Abstract][Full Text] [Related]
34. Volatile Organic Compounds in Exhaled Air as Novel Marker for Disease Activity in Crohn's Disease: A Metabolomic Approach.
Bodelier AG; Smolinska A; Baranska A; Dallinga JW; Mujagic Z; Vanhees K; van den Heuvel T; Masclee AA; Jonkers D; Pierik MJ; van Schooten FJ
Inflamm Bowel Dis; 2015 Aug; 21(8):1776-85. PubMed ID: 26199990
[TBL] [Abstract][Full Text] [Related]
35. Sex and Smoking Status Effects on the Early Detection of Early Lung Cancer in High-Risk Smokers Using an Electronic Nose.
McWilliams A; Beigi P; Srinidhi A; Lam S; MacAulay CE
IEEE Trans Biomed Eng; 2015 Aug; 62(8):2044-54. PubMed ID: 25775482
[TBL] [Abstract][Full Text] [Related]
36. In vitro volatile organic compound profiling using GC×GC-TOFMS to differentiate bacteria associated with lung infections: a proof-of-concept study.
Nizio KD; Perrault KA; Troobnikoff AN; Ueland M; Shoma S; Iredell JR; Middleton PG; Forbes SL
J Breath Res; 2016 Apr; 10(2):026008. PubMed ID: 27120170
[TBL] [Abstract][Full Text] [Related]
37. Identification of metabolomics panels for potential lung cancer screening by analysis of exhaled breath condensate.
Peralbo-Molina A; Calderón-Santiago M; Priego-Capote F; Jurado-Gámez B; Luque de Castro MD
J Breath Res; 2016 Mar; 10(2):026002. PubMed ID: 27007686
[TBL] [Abstract][Full Text] [Related]
38. Metabolomics pilot study to identify volatile organic compound markers of childhood asthma in exhaled breath.
Gahleitner F; Guallar-Hoyas C; Beardsmore CS; Pandya HC; Thomas CP
Bioanalysis; 2013 Sep; 5(18):2239-47. PubMed ID: 24053239
[TBL] [Abstract][Full Text] [Related]
39. In vitro profiling of endothelial volatile organic compounds under resting and pro-inflammatory conditions.
Longo V; Forleo A; Capone S; Scoditti E; Carluccio MA; Siciliano P; Massaro M
Metabolomics; 2019 Oct; 15(10):132. PubMed ID: 31583479
[TBL] [Abstract][Full Text] [Related]
40. Bronchoscopically obtained volatile biomarkers in lung cancer.
Darwiche K; Baumbach JI; Sommerwerck U; Teschler H; Freitag L
Lung; 2011 Dec; 189(6):445-52. PubMed ID: 21968685
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
